Dr. Plisiene was supported by a grant from the German Academic Exchange Service (DAAD).
Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation
Article first published online: 26 JUL 2007
Journal of Cardiovascular Electrophysiology
Volume 18, Issue 10, pages 1076–1082, October 2007
How to Cite
GRAMLEY, F., LORENZEN, J., PLISIENE, J., RAKAUSKAS, M., BENETIS, R., SCHMID, M., AUTSCHBACH, R., KNACKSTEDT, C., SCHIMPF, T., MISCHKE, K., GRESSNER, A., HANRATH, P., KELM, M. and SCHAUERTE, P. (2007), Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 18: 1076–1082. doi: 10.1111/j.1540-8167.2007.00906.x
Manuscript received 15 September 2006; Revised manuscript received 14 April 2007; Accepted for publication 2 May 2007.
- Issue published online: 26 JUL 2007
- Article first published online: 26 JUL 2007
Introduction: Atrial fibrosis has been shown to concur with the persistence of atrial fibrillation (AF) and is only incompletely reversible, thus counteracting attempts to restore and maintain sinus rhythm (SR). Besides the angiotensin system, the matrix metalloproteinases (MMP) play a major role in the pathogenesis of fibrosis. Thus, the present study investigated changes of the MMP system during the development of human AF.
Methods and Results: Right atrial appendages of 146 patients were excised during heart surgery and grouped according to rhythm (SR vs AF) and AF duration. Hydroxyproline as a surrogate for collagen content and morphometrically determined collagen content increased significantly from SR (14.3 ± 7.7%) to chronic permanent AF (CAF) of 6–24 months (21.2 ± 9.2%, P = 0.02), and CAF of > 60 months (25.3 ± 4.7%, P < 0.01). From SR to paroxysmal and chronic persistent AF (CPAF) and to CAF MMP-2 and MMP-9 activity rose, while their mRNA and protein levels were not altered significantly. Plasminogen activator inhibitor (PAI), an inhibitor of a potent activator of many MMPs, was significantly decreased with increasing duration of AF. In parallel, the mRNA levels of the tissue inhibitors of MMPs TIMP-1 and -2 decreased significantly.
Conclusion: Human atrial fibrogenesis is enhanced with increasing duration of AF: a longer AF duration is associated with elevated atrial interstitial MMP activity, but decreased PAI and TIMP expression.